Search

everythinglearnresearchcommunity

for

Search:↓

People with weakened immune systems, like those with SLE, are at higher risk for TB.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Hair gels may cause split ends in children.

Langerhans cells and melanocytes migrate to the skin and hair follicles during early human development.

Iron deficiency might contribute to hair loss in women.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Dupilumab helps children with alopecia areata regrow hair safely.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.